Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1261 |
|---|---|
| Identifier | NCT04033445 |
| Trial Title | A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Placebo|DRUG: Guselkumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Lancaster |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2019-09-26 |
|---|---|
| Primary Completion Date | 2023-09-19 |
| Completion Date | 2027-10-27 |